Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents
US7816075B2 · kind B2 · utility
0Cited by
7References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 11, 2005 |
| Grant date | Oct 19, 2010 |
| Priority date | — |
| Expiry date | Mar 26, 2027 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/90245
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The use of screening assays based on the role of human stearoyl-CoA desaturase-1 (“hSCD1”) in human diseases, disorders or conditions relating to serum levels of triglyceride, VLDL, HDL, LDL, total cholesterol, or production of secretions from mucous membranes, monounsaturated fatty acids, wax esters, and the like, is disclosed. Also disclosed are conventions useful in the prevention and/or treatment of such diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.